RNF43
- and
NOTCH1
-Mutated Chemotherapy and Anti-EGFR-Refractory Colorectal Cancer: Should Clonality Guide Target Prioritization With Investigational Therapies?
JCO Precis Oncol
.
2019 Dec:3:1-3.
doi: 10.1200/PO.19.00182.
Authors
Susana Aguilar
1
,
Cristina Santos
2
,
Giulia Martini
3
,
Guillem Argiles
3
,
Analia Azaro
3
,
Elena Garralda
3
,
Josep Tabernero
3
,
Paolo Nuciforo
1
,
Ana Vivancos
1
,
Rodrigo Dienstmann
1
Affiliations
1
Vall d'Hebron Institute of Oncology, Barcelona, Spain.
2
L'Hospitalet de Llobregat, Barcelona, Spain.
3
Vall d'Hebron University Hospital, Barcelona, Spain.
PMID:
35100710
DOI:
10.1200/PO.19.00182
No abstract available